9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole

9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Basic information
Product Name:9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole
Synonyms:9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole;9-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,2,3,4,4a,9a-hexahydrocarbazole;CP-352664
CAS:1097883-05-0
MF:C18H18N4
MW:290.36232
EINECS:
Product Categories:
Mol File:1097883-05-0.mol
9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Structure
9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Chemical Properties
Safety Information
MSDS Information
9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Usage And Synthesis
UsesCP-352664 is a JAK inhibitor. CP-352664 has a inhibitoinhibits JAK3 with an EC50 value of 210 nM. CP-352664 is promising for research of organ transplant rejection and autoimmune disorders such as rheumatoid arthritis[1].
References[1] Flanagan ME, et al. Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection. J Med Chem. 2010 Dec 23;53(24):8468-84. DOI:10.1021/jm1004286
9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Preparation Products And Raw materials
Tag:9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole(1097883-05-0) Related Product Information
2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-(2,2-dimethyl-1-propoxypropyl)-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)- Ruxolitinib NA gamma-Glu-Cys trifluoroacetate salt Phlorizin Tofacitinib